Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02324647Completed

Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield

Role: collaborator

NCT00854932Not ApplicableUnknown

Neonatal Procalcitonin Intervention Study

Role: collaborator

NCT01752309Completed

The Predictive Value of Ultrasound in Early Rheumatoid Arthritis

Role: collaborator

NCT01132209Not ApplicableCompleted

Suture Techniques to Reduce the Incidence of The inCisional Hernia

Role: collaborator

NCT00895700Not ApplicableUnknown

Internet-based Intervention in Cardioverter-defibrillator Patients to Enhance Quality of Life

Role: collaborator

NCT00126958Unknown

Cost-Effectiveness in Bladder Cancer

Role: collaborator

All 6 trials loaded